Corporate Updates: As part of a strategic review of its pipeline and to enhance operational efficiency and focus, the Company has reduced its workforce by approximately 30%. The majority of the cost savings will result from a workforce reduction in general and administration and non-clinical development. The Company has extended its cash runway, which is now expected into 1H 2026.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ATAI:
- Rising High: Exclusive talk with vertically-integrated MSO Greenlight
- atai Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference
- Rising High: Exclusive talk with funding solutions provider FundCanna
- Here’s What You Missed in Cannabis This Week
- Here’s What You Missed in Cannabis, Psychedelics This Week
